UC San Diego Health Develops COVID-19 Test, Begins Testing Patients
Xconomy
MARCH 13, 2020
The UC San Diego Health System has developed a diagnostic test that can determine whether a patient has contracted the novel coronavirus in about eight hours.
Blogging Develop San Diego 
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns
Xconomy
MARCH 19, 2020
Ciara Kennedy, CEO of clinical-stage antifungal therapy developer Amplyx, is facing a slowdown in trial enrollment as hospitals focus on handling the influx of pandemic patients. The program, originally slated to take.
San Diego 
120
120 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Walmart: Turning San Diego Into Its Technology Center
socalTECH
AUGUST 27, 2018
However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego?
San Diego 100
100 
Walmart: Turning San Diego Into A Key Technology Center
socalTECH
AUGUST 27, 2018
However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego?
San Diego 100
100 
San Diego Tech Roundup: Ezoic, Trust & Will, Oska Wellness & More
Xconomy
AUGUST 9, 2019
Summer can be a slow time in San Diego, but its startups have stayed busy. —Ezoic, a startup that developed software for web publishers that uses machine learning techniques to personalize layouts and ad placements for site visitors, raised $33 million to further develop its technology. .
San Diego 93
93 
AddToAny Bought Back From Lockerz By Founder
socalTECH
JULY 2, 2013
AddToAny , the developer of WordPress and Drupal social sharing plug-ins which got its start at UC San Diego, is back as an independent firm, according to the company''s founder, Pat Diven II. Diven started AddToAny at UC San Diego when he was a student there, although he''s since moved to the Bay Area.
UCSD 147
147 
San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More
Xconomy
JULY 19, 2019
Let’s catch up with the latest tech news in San Diego. —San Diego’s AON Devices was among 10 startups selected to compete at a recent pitch competition hosted by the corporate venture capital arm of Qualcomm (NASDAQ: QCOM ).
San Diego 88
88 
15 San Diego Companies Chosen for Defense Innovation Program
Xconomy
SEPTEMBER 18, 2018
Technology developed in San Diego for defense purposes has helped to seed the region’s private sector with employees who have skills in fields like cybersecurity, engineering, and biotechnology, as well as spur commercial innovation, according to a report published in October by the San Diego Military Advisory Council (SDMAC).
San Diego 76
76 
Event Announcement: Xcelerating Life Sciences San Diego
Xconomy
JANUARY 16, 2020
Each half-day Xcelerating Life Sciences forum is dedicated to helping industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges. Can’t make the San Diego. Early bird tickets are on sale now for only $99. Grab yours today before prices go up.
San Diego 68
68 
Agenda and Speakers Announced for Xcelerating Life Sciences San Diego
Xconomy
JANUARY 29, 2020
Agenda topics include Successful Research & Development Models, What It Takes for Commercialization, and Building a Biotech Ecosystem in San Diego. Join Xconomy as we bring together local innovators, entrepreneurs, and investors to explore bold new ideas in healthcare – and make the impactful connections.
San Diego 79
79 
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs
Xconomy
JULY 8, 2020
Dave Johnson has known UC San Diego physician and cancer reseacher Thomas Kipps for nearly 20 years. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
San Diego 121
121 
San Diego Life Sciences Roundup: ResMed, Alexandria GradLabs & More
Xconomy
MARCH 8, 2019
As we head into the weekend, crossing our fingers that the seemingly endless rain showers will be replaced by our usual sunshine, here’s a quick rundown of some recent news developments. —ResMed (NYSE: RMD ) acquired a South Korea-based medical equipment provider, the company said Friday. Financial terms of the deal weren’t disclosed.
San Diego 82
82 
HipGeo Expands Reach
socalTECH
JANUARY 26, 2012
Fullerton-based HipGeo , the startup developer of a mobile app for tracking a user's travels, said today that the firm is now seeing posts from 125 countries and over 4,864 cities on its app. executives Ash Patel and Michael Marquez, Galen Buckwalter, the former Chief Scientist of eHarmony, and San Diego angel investor Robert Bingham.
eHarmony 174
174 Locana, Fueled With $55M, Looks to Develop Fixes for Faulty RNA
Xconomy
JUNE 21, 2019
Locana, a gene therapy biotech in San Diego, is taking what it describes as a “parallel path” to developing therapeutics that could potentially fix diseases by changing our genetic code through altering DNA’s molecular compatriot, RNA.
Develop 84
84 
Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease
Xconomy
JUNE 23, 2020
Headed by president and CEO Niall O’Donnell (pictured), the San Diego-based company launched last year with $50 million and an investigational small molecule drug it licensed from High Point, NC-based vTv Therapeutics (NASDAQ: VTVT ). The molecule, REN001, is being developed for patients with primary mitochondrial myopathies (PMM).
San Diego 127
127 
Biomed Incubator Watershed Develops Tech for IDing Medical Devices
Xconomy
SEPTEMBER 27, 2017
San Antonio — A biomedical product developer, Watershed Idea Foundry, has created a method of identifying medical devices that have been implanted in the body that uses 3-D printing and its own software.
Incubator 108
108 
Xconomy Forum Rides Wave of Big Data/Big Bio Startups in San Diego
Xconomy
APRIL 17, 2018
The company developed automated kiosks that would scan a device and use analytic software to calculate what it was worth and how much of a rebate to offer for it. Founded by several veterans of the wireless semiconductor industry , EcoATM created a business where there wasn’t one for recycling smartphones and other electronic devices.
San Diego 79
79 
Study Stakes San Diego’s Claim in Genomics: $292M in 2016 VC Deals
Xconomy
MAY 18, 2017
Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. The San Diego Regional Economic Development Corp. began collecting data for the report earlier this year in a bid to assess how genomics fits into San Diego’s innovation economy.
Study 97
97 
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
Xconomy
MARCH 28, 2019
Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme. The company began focusing on the technology it is currently developing in 2015, Tagney said. The San Diego startup.
San Diego 103
103 
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal
Xconomy
SEPTEMBER 21, 2020
Grail is set to be acquired for $8 billion by Illumina, the gene sequencing giant that formed the cancer diagnostics developer and spun it out as a separate company four years ago. The announcement comes less than two weeks after Menlo Park, CA-based Grail revealed its plans for an IPO to support commercialization of its first test next year.
Develop 111
111 
Arcturus Poised to Move Liver Drug, COVID-19 Vaccine Into Clinic
Xconomy
APRIL 14, 2020
Messenger RNA drug developer Arcturus Therapeutics is ready to kick off its first-ever human trials this year, beginning clinical evaluation of its lead drug candidate and testing a vaccine designed to target the novel coronavirus.
Arcturus 117
117 
Trovagene Rebrands as Cardiff Oncology, Promotes Longtime Exec to CEO
Xconomy
MAY 7, 2020
In 2017 the San Diego area-based biotech made the first step in its transformation into a drug development-focused organization, licensing rights to an investigational cancer drug from Italy’s Nerviano Medical Sciences.
San Diego 106
106 
UCSD, 5 Diagnostic Makers Partner to Ramp COVID-19 Testing Capacity
Xconomy
MARCH 20, 2020
A group of scientists and physicians at UC San Diego Health and the UCSD School of Medicine has arranged a partnership with five diagnostics markers that it says will bring the health system’s capacity to test for coronavirus to as many as 1,500 tests daily sometime in early April.
UCSD 93
93 
Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers
Xconomy
APRIL 7, 2020
Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA’s OK to start testing its candidate in healthy volunteers. The Plymouth Meeting, PA-based company, which also conducts research in San Diego, plans to enroll as many as 40 adults across two trial locations.
San Diego 108
108 
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
Xconomy
DECEMBER 19, 2018
Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices. RiverVest Venture Partners, a St.
San Diego 107
107 
Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies
Xconomy
JUNE 26, 2020
Biotech veterans Tom Farrell and Peter Flynn have teamed up to start a new San Diego company that aims to develop allogeneic, or off-the-shelf, cell-based immunotherapies using natural killer (NK) cells that can be manufactured at scale and delivered to cancer patients outside of the hospital.
San Diego 107
107 
FDA OKs Banyan Diagnostic, the First Blood Test for Concussions
Xconomy
FEBRUARY 14, 2018
The approval goes to San Diego diagnostics developer Banyan Biomarkers. The company developed the test with partial support from a contract with the U.S.
San Diego 102
102 
Nestlé Sells Gut-Health Test Maker Prometheus Labs, Layoffs Expected
Xconomy
JULY 10, 2019
Eight years after San Diego biotech Prometheus Laboratories was acquired by Nestlé Health Science , the diagnostic business has been sold again, this time to a little-known biotech called Precision IBD that plans to lay off approximately a quarter of Prometheus’s workforce.
Layoffs 91
91 
Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis
Xconomy
JANUARY 9, 2020
Empirico, a biotech that has developed tools to analyze genomics data and use those insights to identify potential therapeutic targets, has signed a collaboration deal with antisense drug developer Ionis Pharmaceuticals that includes a $10 million equity investment. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.
San Diego 98
98 TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push
Xconomy
OCTOBER 19, 2018
The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday. Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.
San Diego 97
97 
La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War
Xconomy
JUNE 24, 2020
It’s common for antibiotics developers to run into financial trouble these days but what’s unusual is seeing a bidding war erupt for one of them. The competition for Tetraphase Pharmaceuticals now has a new winner : La Jolla Pharmaceutical.
San Diego 101
101 Reveal Biosciences Gets Intel’s Backing on “AI-Powered” Pathology
Xconomy
APRIL 3, 2019
A 25-person startup developing advanced computing tools to speed up pathology work has raised its first institutional financing from a group of investors led by Intel Capital, the corporate investment arm of the chipmaker.
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
Xconomy
AUGUST 26, 2020
The San Diego-based company splashed out $52.5 Acadia agreed to pay CerSci shareholders up to $887 million more in payments depending on development, commercialization, and sales milestones, plus royalties. million on the buyout, a cash-and-stock deal—$47.2
San Diego 102
102 
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M
Xconomy
SEPTEMBER 19, 2019
The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA. Zach Hornby, former chief.
San Diego 102
102 
Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments
Xconomy
MARCH 15, 2019
A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA. The company, which CEO Bob Manning says has raised about $2.5
Customer 76
76 
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs
Xconomy
MARCH 22, 2019
Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO. The company, which started operations in 2014, has raised nearly $148 million since inception. Drugs already exist for some cancers associated with those.
San Diego 88
88 
Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup
Xconomy
AUGUST 11, 2020
San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. The company reported revenues of about $120.3 million in 2019.
San Diego 98
98 Sanford Burnham Prebys, WARF Partner on Drug Discovery
Xconomy
MARCH 25, 2019
The San Diego-area medical research institute inked a similar deal with the Mayo Clinic in 2012. The partnership is part of a broader movement to accelerate the “bench to bedside” process by better integrating those in academia, government, and industry in the hopes of more rapidly pushing ahead pharmaceutical innovation.
San Diego 107
107 With $75M Alumnus Gift, UCSD Opens Data Science Institute
Xconomy
MARCH 2, 2018
Amid intensifying global demand for workers who can extract insights from zettabytes of data, the University of California, San Diego held a dedication ceremony Friday for its new Halicio?lu The center, made possible by a $75 million gift from UC San Diego alumnus and early Facebook employee Taner Halicio?lu,
UCSD 79
79 
Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug
Xconomy
SEPTEMBER 17, 2019
On Monday, the clinical-stage San Diego biotech company announced it had added an experimental drug developed by Swiss pharma giant Novartis (NYSE: NVS ) to its pipeline through a licensing deal.
San Diego 90
90 This Week in VC with Farb Nivi, Founder of Grockit
Both Sides of the Table
JUNE 3, 2010
Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. I don’t do advertising on my blog, but I thought it was worth mentioning Ryan in particular because he has an alternate model for doing a startup. Developer of Appsaurus , a mobile app recommendation engine. Hello, Chair.
Venture Capital 214
214 
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic
Xconomy
JANUARY 6, 2020
In the past seven years BioIntervene has been working to develop “ultra-selective” compounds to target an adenosine receptor associated with pain relief. Now the San Diego-based biotech has $30 million and a chief scientific officer, Charles Cohen, to guide its lead compound, BIO-205, into human testing for neuropathic pain.
San Diego 97
97 
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Xconomy
MARCH 27, 2019
San Diego-based Acadia (NASDAQ: ACAD ) announced in August that it had licensed the drug, trofinetide, for development and commercialization in North America as a treatment for Rett syndrome and other indications, including Fragile X syndrome.
San Diego 97
97 
Nominations Open for San Diego’s Inaugural Xconomy Awards
Xconomy
NOVEMBER 8, 2018
San Diego is one of the top U.S. Researchers and entrepreneurs here are leaders in developing the next generation of medicines and medical devices. Hundreds of companies. Dozens of research institutes. Billions of dollars in economic impact. cities for innovation in life sciences and healthtech.
San Diego 82
82 
Let's personalize your content